Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
latest_posts
- 1
There are thousands of aligned holes in Peru. Archaeologists now think they know who made them - 2Israel launches new wave of attacks against Hezbollah in Beirut
- 3Sound Maturing: Wellbeing Tips for Each Life Stage
- 4Get away from the Tedious Drudgery: Go into Business Today!
- 5Global measles cases drop 71% in 24 years as vaccination coverage improves, WHO says
- Is relief in sight? Flu season still brutal but cases are declining.
- 10 times the sky amazed us in 2025
- ‘Raising 10 red flags’: Is Israel’s army exhausted?
- Israel and Iran continue tit-for-tat attacks
- How a Middle East War Becomes a Retail Price Hike
- The Main 20 Gaming Control center Ever
- A Timeline of Rising Antisemitism in Australia
- Americans generally like wolves − except when we’re reminded of our politics
- Spots to Go Hang Floating
